Simple blood test may spot hidden scarring in arthritis patients
NCT ID NCT07393217
First seen Feb 06, 2026 · Last updated Jun 23, 2026 · Updated 17 times
Summary
This study will measure a blood protein called FAP, which is linked to tissue scarring and inflammation, in people with rheumatoid arthritis or systemic sclerosis and in healthy volunteers. Researchers want to see if FAP levels match up with standard disease activity scores and lung function tests. The goal is to find out whether FAP could become a useful blood marker for monitoring these conditions. Participation does not change usual medical care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sohag University Hospital
Sohag, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple blood test to help doctors monitor disease activity and lung scarring in rheumatoid arthritis and systemic sclerosis.
What could go wrong
This is an early observational study, not a treatment trial. The blood marker may not prove useful in practice, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.